SABBY MANAGEMENT, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 26 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q4 2022$52,025
-90.1%
11,905
-87.3%
0.05%
-93.1%
Q3 2022$528,000
+59.0%
94,005
+63.2%
0.67%
+194.7%
Q2 2022$332,000
+9.2%
57,589
+92.2%
0.23%
+402.2%
Q1 2022$304,000
-70.9%
29,962
-84.7%
0.04%
-69.4%
Q2 2021$1,045,000
+69.1%
196,033
+22.4%
0.15%
+22.5%
Q1 2021$618,000160,1820.12%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders